These results suggest that double-hit and triple-hit DLBCL cell lines are sensitive to BET bromodomain inhibitors and the anti-proliferative effect is comparable to cells expressing no MYC rearrangements. This evidence concerns the gene MYC and diffuse large B-cell lymphoma.